Gene · 6012
Papers2,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gender-Specific Impact of Sex Hormones on the Immune System. | Int J Mol Sci | 2023 | 37047274 | PubTator, text mining | PubMed |
| Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry? | Int J Mol Sci | 2023 | 37047226 | PubTator, text mining | PubMed |
| Contribution of the L-Type Amino Acid Transporter Family in the Diagnosis and Treatment of Prostate Cancer. | Int J Mol Sci | 2023 | 37047148 | PubTator, text mining | PubMed |
| Clinical features and risk factors of lung cancer in elderly patients with dermatomyositis. | Thorac Cancer | 2023 | 37042120 | PubTator, text mining | PubMed |
| The versatile characteristics of Ars/SGaInS van der Waals heterostructures. | Phys Chem Chem Phys | 2023 | 37038754 | PubTator, text mining | PubMed |
| MicroRNAs-mediated regulation of the differentiation of dental pulp-derived mesenchymal stem cells: a systematic review and bioinformatic analysis. | Stem Cell Res Ther | 2023 | 37038220 | PubTator, text mining | PubMed |
| Pregnancy course and outcomes of patients with polymyositis and dermatomyositis (PM/DM) managed in a single center. | Medicine (Baltimore) | 2023 | 37026900 | PubTator, text mining | PubMed |
| The epigenetic function of androgen receptor in prostate cancer progression. | Front Cell Dev Biol | 2023 | 37025180 | PubTator, text mining | PubMed |
| Molecular basis and therapeutic targets in prostate cancer: A comprehensive review. | Biomol Biomed | 2023 | 37021836 | PubTator, text mining | PubMed |
| A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations. | Hum Mol Genet | 2023 | 37010095 | PubTator, text mining | PubMed |
| Elucidating molecular and cellular targets and the antiprostate cancer potentials of promising phytochemicals: a review. | Anticancer Drugs | 2023 | 36995078 | PubTator, text mining | PubMed |
| Efficacy and selectivity of tumor-treating field therapy for triple-negative breast cancer cells via in-house delivery device. | Discov Oncol | 2023 | 36991198 | PubTator, text mining | PubMed |
| Risk factors for cardiovascular events in patients with heterozygous familial hypercholesterolaemia: protocol for a systematic review. | BMJ Open | 2023 | 36990476 | PubTator, text mining | PubMed |
| Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome. | Int J Mol Sci | 2023 | 36982560 | PubTator, text mining | PubMed |
| Forward Genetics-Based Approaches to Understanding the Systems Biology and Molecular Mechanisms of Epilepsy. | Int J Mol Sci | 2023 | 36982355 | PubTator, text mining | PubMed |
| Coelenterazine-Type Bioluminescence-Induced Optical Probes for Sensing and Controlling Biological Processes. | Int J Mol Sci | 2023 | 36982148 | PubTator, text mining | PubMed |
| Multiple Sulfatase Deficiency from an Ophthalmologist's Perspective-Case Report and Literature Review. | Children (Basel) | 2023 | 36980153 | PubTator, text mining | PubMed |
| State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancer. | Front Oncol | 2023 | 36969009 | PubTator, text mining | PubMed |
| The association between clinical, subclinical features and autoantibody profile in Vietnamese dermatomyositis patients. | PLOS Glob Public Health | 2023 | 36962887 | PubTator, text mining | PubMed |
| Electroacupuncture activated local sympathetic noradrenergic signaling to relieve synovitis and referred pain behaviors in knee osteoarthritis rats. | Front Mol Neurosci | 2023 | 36959872 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6012/papers?page=19